GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (CHIX:PFEd) » Definitions » Cyclically Adjusted FCF per Share

Pfizer (CHIX:PFED) Cyclically Adjusted FCF per Share : €2.77 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Pfizer Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pfizer's adjusted free cash flow per share for the three months ended in Dec. 2023 was €0.681. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €2.77 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Pfizer's average Cyclically Adjusted FCF Growth Rate was -3.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 7.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Pfizer was 29.20% per year. The lowest was 0.80% per year. And the median was 11.95% per year.

As of today (2024-05-01), Pfizer's current stock price is €24.095. Pfizer's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was €2.77. Pfizer's Cyclically Adjusted Price-to-FCF of today is 8.70.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pfizer was 21.47. The lowest was 8.22. And the median was 14.39.


Pfizer Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Pfizer's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Cyclically Adjusted FCF per Share Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.71 19.90 24.92 33.42 2.77

Pfizer Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.42 3.00 3.27 2.91 2.77

Competitive Comparison of Pfizer's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted Price-to-FCF falls into.



Pfizer Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.681/129.4194*129.4194
=0.681

Current CPI (Dec. 2023) = 129.4194.

Pfizer Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.294 99.695 0.382
201406 0.429 100.560 0.552
201409 0.473 100.428 0.610
201412 0.662 99.070 0.865
201503 0.064 99.621 0.083
201506 0.546 100.684 0.702
201509 0.670 100.392 0.864
201512 0.622 99.792 0.807
201603 0.217 100.470 0.280
201606 0.450 101.688 0.573
201609 0.624 101.861 0.793
201612 0.818 101.863 1.039
201703 0.188 102.862 0.237
201706 0.406 103.349 0.508
201709 0.596 104.136 0.741
201712 0.881 104.011 1.096
201803 0.210 105.290 0.258
201806 0.492 106.317 0.599
201809 0.672 106.507 0.817
201812 0.595 105.998 0.726
201903 0.166 107.251 0.200
201906 0.316 108.070 0.378
201909 0.619 108.329 0.740
201912 0.574 108.420 0.685
202003 0.433 108.902 0.515
202006 0.490 108.767 0.583
202009 0.239 109.815 0.282
202012 0.699 109.897 0.823
202103 0.591 111.754 0.684
202106 1.573 114.631 1.776
202109 1.516 115.734 1.695
202112 0.754 117.630 0.830
202203 0.930 121.301 0.992
202206 1.229 125.017 1.272
202209 0.907 125.227 0.937
202212 1.246 125.222 1.288
202303 0.012 127.348 0.012
202306 -0.343 128.729 -0.345
202309 0.439 129.860 0.438
202312 0.681 129.419 0.681

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Pfizer  (CHIX:PFEd) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pfizer's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=24.095/2.77
=8.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pfizer was 21.47. The lowest was 8.22. And the median was 14.39.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pfizer Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Pfizer's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (CHIX:PFED) Business Description

Industry
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (CHIX:PFED) Headlines

From GuruFocus

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 08-16-2010

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-15-2010

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 05-17-2010

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-16-2009